cas 929-59-9|| where to buy Bis-NH2-PEG2

Nom du produit:Bis-NH2-PEG2

IUPAC Name:2-[2-(2-aminoethoxy)ethoxy]ethan-1-amine

Unité d'emballage	Stock disponible	Prix($)
CM117552-100g	in stock	Ȑǫ
CM117552-500g	in stock	Ǒƛȯ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 929-59-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:929-59-9; Formule moléculaire:C6H16N2O2; Point de fusion:-; Code SMILES:NCCOCCOCCN; Densité:

: Numéro de catalogue:CM117552; Poids moléculaire:148.21; Point d'ébullition:; N° Mdl:MFCD00040474; Stockage:

: PROTAC-Linkers; PROTACs (Proteolytic Targeting Chimeric Molecules) are heterobifunctional protein degraders and are promising targeted therapy candidates for cancer. PROTAC is composed of three parts, one end is connected with the ligand bound by E3 ligase, the other end is connected with the ligand bound by the target protein, and the middle is the linker.; Protac Linkers; where to buy PROTAC-Linkers, Chemenu is research-based manufacturer of pharmaceutical intermediates. We supply Protac Linkers with low price.Warmly welcome new and old customers to visit!

: Nitrogen Compounds; Nitrogen compounds can be classified as mineral or organic. Mineral compounds are essentially formed by the ammonium ion (NH4+), which is generated when ammonium salts are dissolved in water. Organic compounds, in contrast, are carbon and hydrogen compounds that contain a nitrogen atom. All organic nitrogen-containing compounds can be considered as derivatives of ammonia in which one or more hydrogen atoms are substituted by hydrocarbon radicals.

: Tenapanor; FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.